• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪因子在糖尿病和肥胖症治疗中的应用

Adipokines in the treatment of diabetes mellitus and obesity.

作者信息

Catalán Victoria, Gómez-Ambrosi Javier, Rodríguez Amaia, Salvador Javier, Frühbeck Gema

机构信息

Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain.

出版信息

Expert Opin Pharmacother. 2009 Feb;10(2):239-54. doi: 10.1517/14656560802618811.

DOI:10.1517/14656560802618811
PMID:19236196
Abstract

BACKGROUND

The physiology of adipose tissue plays a main role in the pathogenesis of type 2 diabetes mellitus. The secretion of adipocyte-derived hormones, in either an autocrine or a paracrine manner, has been proposed as a relevant mechanism in this process. In this sense, the administration and regulation of hormones derived from adipose tissue arises as an attractive option for treating metabolic disorders.

OBJECTIVE

To review the current understanding of the implication of adipokines in the development of obesity and insulin resistance, as well as their potential use as therapeutic agents.

METHODOLOGY

Review of scientific literature.

CONCLUSIONS

This review describes the role of adipokines in generating insulin resistance and the chronic low-grade inflammatory profile accompanying visceral obesity.

摘要

背景

脂肪组织的生理学在2型糖尿病的发病机制中起主要作用。脂肪细胞衍生激素以自分泌或旁分泌方式分泌,被认为是这一过程中的相关机制。从这个意义上说,给予和调节源自脂肪组织的激素成为治疗代谢紊乱的一个有吸引力的选择。

目的

综述目前对脂肪因子在肥胖和胰岛素抵抗发生发展中的作用及其作为治疗药物的潜在用途的认识。

方法

对科学文献进行综述。

结论

本综述描述了脂肪因子在产生胰岛素抵抗以及伴随内脏肥胖的慢性低度炎症状态中的作用。

相似文献

1
Adipokines in the treatment of diabetes mellitus and obesity.脂肪因子在糖尿病和肥胖症治疗中的应用
Expert Opin Pharmacother. 2009 Feb;10(2):239-54. doi: 10.1517/14656560802618811.
2
Cardiovascular risk of adipokines: a review.脂肪因子的心血管风险:综述
J Int Med Res. 2018 Jun;46(6):2082-2095. doi: 10.1177/0300060517706578. Epub 2017 Sep 25.
3
Adipokines at the crossroad between obesity and cardiovascular disease.肥胖与心血管疾病交叉点上的脂肪因子
Thromb Haemost. 2015 Mar;113(3):553-66. doi: 10.1160/TH14-06-0513. Epub 2014 Oct 23.
4
[Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].[低度全身炎症与代谢性疾病的发生发展:从分子证据到临床实践]
Cir Cir. 2015 Nov-Dec;83(6):543-51. doi: 10.1016/j.circir.2015.05.041. Epub 2015 Jul 6.
5
Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors.不同腹部脂肪组织储存部位的炎症特征与心血管疾病的代谢危险因素存在不同关联:不同的脂肪储存部位与血管危险因素。
Atherosclerosis. 2015 Apr;239(2):419-27. doi: 10.1016/j.atherosclerosis.2015.01.035. Epub 2015 Feb 2.
6
Role of adipocytokines in obesity-associated insulin resistance.脂肪细胞因子在肥胖相关胰岛素抵抗中的作用。
J Nutr Biochem. 2008 May;19(5):277-86. doi: 10.1016/j.jnutbio.2007.06.006. Epub 2007 Nov 28.
7
Osteoarthritis, obesity and type 2 diabetes: The weight of waist circumference.骨关节炎、肥胖症和 2 型糖尿病:腰围的重量。
Ann Phys Rehabil Med. 2016 Jun;59(3):157-160. doi: 10.1016/j.rehab.2016.04.002. Epub 2016 May 19.
8
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.肥胖症中的肝脂肪:2 型糖尿病和脂肪组织分布的作用。
Eur J Clin Invest. 2011 Jan;41(1):39-44. doi: 10.1111/j.1365-2362.2010.02372.x. Epub 2010 Sep 6.
9
Visceral fat and insulin resistance - what we know?内脏脂肪与胰岛素抵抗——我们了解什么?
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):19-27. doi: 10.5507/bp.2018.062. Epub 2018 Nov 6.
10
Adipose tissue as an endocrine organ.脂肪组织作为一种内分泌器官。
Clin Liver Dis. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012.

引用本文的文献

1
Assessment of serum and salivary resistin levels in newly diagnosed type-II diabetes mellitus patients.新诊断的II型糖尿病患者血清和唾液抵抗素水平的评估。
J Oral Maxillofac Pathol. 2025 Apr-Jun;29(2):254-259. doi: 10.4103/jomfp.jomfp_219_24. Epub 2025 Jun 30.
2
Polydatin Inhibits Adipose Tissue Inflammation and Ameliorates Lipid Metabolism in High-Fat-Fed Mice.虎杖苷抑制高脂肪喂养小鼠脂肪组织炎症并改善脂代谢。
Biomed Res Int. 2019 Nov 15;2019:7196535. doi: 10.1155/2019/7196535. eCollection 2019.
3
Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort.
细胞因子与糖尿病进展的相关性估计:基于社区队列的 10 年随访。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e381-9. doi: 10.1210/clinem/dgz171.
4
Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass.肥胖合并 2 型糖尿病患者行 Roux-en-Y 胃旁路术后脂联素/瘦素比值的变化。
Nutrients. 2019 Sep 3;11(9):2069. doi: 10.3390/nu11092069.
5
Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.补充n-3多不饱和脂肪酸对2型糖尿病患者代谢和炎症生物标志物的影响。
Nutrients. 2017 Jun 3;9(6):573. doi: 10.3390/nu9060573.
6
Specific Strains of Lactic Acid Bacteria Differentially Modulate the Profile of Adipokines .特定乳酸菌菌株对脂肪因子谱具有不同的调节作用。
Front Immunol. 2017 Mar 13;8:266. doi: 10.3389/fimmu.2017.00266. eCollection 2017.
7
Identification of active miRNA and transcription factor regulatory pathways in human obesity-related inflammation.人类肥胖相关炎症中活性微小RNA和转录因子调控通路的鉴定
BMC Bioinformatics. 2015 Mar 7;16:76. doi: 10.1186/s12859-015-0512-5.
8
Mechanisms linking excess adiposity and carcinogenesis promotion.将过多肥胖与致癌作用促进联系起来的机制。
Front Endocrinol (Lausanne). 2014 May 1;5:65. doi: 10.3389/fendo.2014.00065. eCollection 2014.
9
Adipokines - removing road blocks to obesity and diabetes therapy.脂肪因子——消除肥胖症和糖尿病治疗的障碍
Mol Metab. 2014 Jan 21;3(3):230-40. doi: 10.1016/j.molmet.2014.01.005. eCollection 2014 Jun.
10
Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans.胃旁路手术和袖状胃切除术对人体血浆骨桥蛋白浓度的比较影响。
Surg Endosc. 2014 Aug;28(8):2412-20. doi: 10.1007/s00464-014-3490-1. Epub 2014 Mar 13.